Literature DB >> 15175538

Nicotine delivery capabilities of smokeless tobacco products and implications for control of tobacco dependence in South Africa.

O A Ayo-Yusuf1, T J P Swart, W B Pickworth.   

Abstract

OBJECTIVES: Smokeless tobacco (SLT) use is popular among black South African women and children. The study sought to determine the nicotine delivery capability of popular industrialised and traditional SLT brands in South Africa, and to provide information for policy action by regulatory authorities.
DESIGN: Laboratory chemical analysis of four industrialised and one traditional SLT products commercially available, using previously published analytical methods. Potential for dependence was inferred from nicotine delivery capabilities determined by the percentage free base nicotine. MEASUREMENTS: Moisture, pH, total nicotine, and percentage free base nicotine.
RESULTS: Total nicotine content was between 6-16 mg/g. The pH varied between 7-10 and this correlated with percentage free base nicotine, which ranged between 10-99%. The nicotine delivery capability of the traditional product was lower than that of the industrialised products except for the recently introduced portion bag snus, which had comparable total nicotine but the lowest pH and percentage free base nicotine. The most popular SLT brands showed the highest percentage free base nicotine ever reported for any industrialised SLT or cigarette brands. Small cans contained higher nicotine than the large cans of the same brand tested. Findings from the study support a potential for limited "product graduation" by users.
CONCLUSIONS: South African SLT users are mostly exposed to potentially very highly addictive levels of nicotine that may favour tobacco dependence and its consequent health risks. The increasing use of SLT by women of childbearing age support the need for intensified policy action to control its use.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15175538      PMCID: PMC1747856          DOI: 10.1136/tc.2003.006601

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  27 in total

1.  Pharmacokinetics and pharmacodynamics of moist snuff in humans.

Authors:  R V Fant; J E Henningfield; R A Nelson; W B Pickworth
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

2.  Extent of smoking and nicotine dependence in the United States: 1991-1993.

Authors:  D B Kandel; K Chen
Journal:  Nicotine Tob Res       Date:  2000-08       Impact factor: 4.244

3.  Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans.

Authors:  Neal L Benowitz; Eliseo J Pérez-Stable; Brenda Herrera; Peyton Jacob
Journal:  J Natl Cancer Inst       Date:  2002-01-16       Impact factor: 13.506

4.  Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction.

Authors:  L T Kozlowski; A A Strasser; G A Giovino; P A Erickson; J V Terza
Journal:  Tob Control       Date:  2001-09       Impact factor: 7.552

5.  Comparison of the nicotine content of tobacco used in bidis and conventional cigarettes.

Authors:  J L Malson; K Sims; R Murty; W B Pickworth
Journal:  Tob Control       Date:  2001-06       Impact factor: 7.552

6.  Recent trends in smoking prevalence in South Africa--some evidence from AMPS data.

Authors:  Corné van Walbeek
Journal:  S Afr Med J       Date:  2002-06

Review 7.  The Swedish snus and the Sudanese toombak: are they different?

Authors:  A M Idris; S O Ibrahim; E N Vasstrand; A C Johannessen; J R Lillehaug; B Magnusson; M Wallström; J M Hirsch; R Nilsen
Journal:  Oral Oncol       Date:  1998-11       Impact factor: 5.337

8.  Smokeless tobacco use among adults in the Northern Province of South Africa: qualitative data from focus groups.

Authors:  K Peltzer; N Phaswana; D Malaka
Journal:  Subst Use Misuse       Date:  2001-03       Impact factor: 2.164

9.  Tobacco use in South Africans during 1998: the first demographic and health survey.

Authors:  Krisela Steyn; Debbie Bradshaw; Rosana Norman; Ria Laubscher; Yussuf Saloojee
Journal:  J Cardiovasc Risk       Date:  2002-06

10.  Smokeless tobacco use and cancer of the upper respiratory tract.

Authors:  Brad Rodu; Philip Cole
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2002-05
View more
  5 in total

1.  Pitfalls in the assessment of smoking status detected in a cohort of South African RA patients.

Authors:  Nimmisha Govind; Mahmood M T M Ally; Mohammed Tikly; Ronald Anderson; Bridget Hodkinson; Pieter W A Meyer
Journal:  Rheumatol Int       Date:  2016-07-08       Impact factor: 2.631

Review 2.  Toward a comprehensive long term nicotine policy.

Authors:  N Gray; J E Henningfield; N L Benowitz; G N Connolly; C Dresler; K Fagerstrom; M J Jarvis; P Boyle
Journal:  Tob Control       Date:  2005-06       Impact factor: 7.552

3.  Missed opportunities for tobacco use screening and brief cessation advice in South African primary health care: a cross-sectional study.

Authors:  Olufemi B Omole; Kabilabe N W Ngobale; Olalekan A Ayo-Yusuf
Journal:  BMC Fam Pract       Date:  2010-11-29       Impact factor: 2.497

4.  Tobacco use and secondhand smoke exposure during pregnancy in two African countries: Zambia and the Democratic Republic of the Congo.

Authors:  Elwyn Chomba; Antoinette Tshefu; Marie Onyamboko; Christine Kaseba-Sata; Janet Moore; Elizabeth M McClure; Nancy Moss; Norman Goco; Michele Bloch; Robert L Goldenberg
Journal:  Acta Obstet Gynecol Scand       Date:  2010       Impact factor: 4.544

5.  Smokeless tobacco use as a risk factor for periodontal disease.

Authors:  Kavitha P Kamath; Supriya Mishra; Pradeep S Anand
Journal:  Front Public Health       Date:  2014-10-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.